1,718.00p+74.00 (+4.50%)22 Nov 2024, 16:35
Jump to:
Genus PLC Fundamentals
Company Name | Genus PLC | Last Updated | 2024-11-22 |
---|---|---|---|
Industry | Biotechnology | Sector | Healthcare |
Shares in Issue | 65.690 m | Market Cap | £1.13 bn |
PE Ratio | 138.15 | Dividend per Share | £0.32 |
Dividend Yield | 1.95 | Dividend Cover | 0.37 |
EPS | £0.12 | EPS Growth (%) | -0.27 |
PEG | 0 | DPS Growth (%) | 0 |
Debt Ratio | 0.2830 | Debt Equity Ratio | 0.5018 |
Asset Equity Ratio | 1.8917 | Cash Equity Ratio | 0.0781 |
Quick Ratio | 1.0956 | Current Ratio | 1.80 |
Price To Book Value | 1.9901 | ROCE | 0 |
Genus PLC Dividends
Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
---|---|---|---|---|---|
Prelim | 2024-11-07 | 2024-12-06 | GBP | 0.2170 | |
Interim | 2024-02-29 | 2024-03-28 | GBP | 0.1030 | |
Prelim | 2023-11-09 | 2023-12-08 | GBP | 0.2170 | |
Interim | 2023-03-02 | 2023-03-30 | GBP | 0.1030 | |
Prelim | 2022-11-17 | 2022-12-09 | GBP | 0.2170 | |
Interim | 2022-03-03 | 2022-03-31 | GBP | 0.1030 | |
Prelim | 2021-11-18 | 2021-12-10 | GBP | 0.2170 |
Genus PLC Company Financials
Assets | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Tangible Assets | £182.00 m | £164.40 m | £171.40 m | £123.00 m |
Intangible Assets | £175.70 m | £174.00 m | £183.00 m | £157.80 m |
Investments | £61.60 m | £62.30 m | £51.40 m | £48.80 m |
Total Fixed Assets | £757.80 m | £748.50 m | £760.40 m | £619.30 m |
Stocks | £89.40 m | £85.10 m | £84.00 m | £76.60 m |
Debtors | £122.50 m | £122.00 m | £119.40 m | £96.30 m |
Cash & Equivalents | £42.50 m | £36.30 m | £38.80 m | £46.00 m |
Other Assets | £338.50 m | £347.80 m | £354.60 m | £289.70 m |
Total Assets | £1.03 bn | £1.01 bn | £1.02 bn | £851.00 m |
Liabilities | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Creditors within 1 year | £150.60 m | £147.20 m | £151.30 m | £142.50 m |
Creditors after 1 year | £334.40 m | £293.10 m | £294.50 m | £211.90 m |
Other Liabilities | 0 | 0 | 0 | 0 |
Total Liabilities | £485.00 m | £440.30 m | £445.80 m | £354.40 m |
Net assets | £543.90 m | £567.20 m | £572.10 m | £496.60 m |
Equity | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Called up share capital | £6.60 m | £6.60 m | £6.60 m | £6.60 m |
Share Premium | £179.10 m | £179.10 m | £179.10 m | £179.10 m |
Profit / Loss | £5.50 m | £39.40 m | £48.40 m | £55.80 m |
Other Equity | £542.70 m | £569.40 m | £572.80 m | £493.00 m |
Preference & Minorities | £1.20 m | -£2.20 m | -£700,000.00 | £3.60 m |
Total Capital Employed | £543.90 m | £567.20 m | £572.10 m | £496.60 m |
Ratios | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Debt Ratio | £0.33 | £0.28 | £0.27 | £0.21 |
Debt-to-Equity | £0.50 | £0.38 | £0.36 | £0.26 |
Assets / Equity | 1.8917 | 1.8917 | 1.8917 | 1.8917 |
Cash / Equity | 0.0781 | 0.0781 | 0.0781 | 0.0781 |
EPS | £0.40 | £0.55 | £0.65 | £0.77 |
Cash Flow | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Cash from operating activities | £29.80 m | £50.40 m | £34.30 m | £67.50 m |
Cashflow before financing | £27.00 m | £32.20 m | £56.20 m | £53.30 m |
Increase in Cash | £7.70 m | £1.30 m | -£11.00 m | £6.60 m |
Income | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Turnover | £668.80 m | £689.70 m | £593.40 m | £574.30 m |
Cost of sales | £490.10 m | £502.20 m | £445.50 m | £420.40 m |
Gross Profit | £178.70 m | £187.50 m | £147.90 m | £153.90 m |
Operating Profit | £6.40 m | £40.50 m | £49.40 m | £47.70 m |
Pre-Tax profit | £5.50 m | £39.40 m | £48.40 m | £55.80 m |
Genus PLC Company Background
Sector | Healthcare |
---|---|
Activities | Genus PLC is a biotechnology company that develops animal genetics for agricultural purposes. The company breeds and distributes the genes of pigs and bulls, scientifically selecting livestock whose offspring are designed to increase the profitability of its customers. In the porcine market, Genus sells boars and sows that produce offspring with desirable characteristics, such as feed-efficient growth or leaner meat. In the dairy and beef markets, the company's primary product is bull semen, which is delivered through artificial insemination to improve its customers' herds and their efficiency. Genus also offers embryos through its subsidiary IVB. |
Latest Interim Date | 22 Feb 2024 |
Latest Fiscal Year End Date | 5 Sep 2024 |
Genus PLC Directors
Appointed | Name | Position |
---|---|---|
2023-09-30 | Mr. Stephen David Wilson | Executive Director |
2014-11-14 | Professor Barry Furr, OBE | Non-Executive Director |
2018-11-15 | Mr. Philip Noel Nigel Turner | Non-Executive Director |
2011-10-12 | Mr. Richard Kenneth Wood | Executive Director,Chief Executive Officer |
2022-10-14 | Mr. Robert Arthur Lawson | Non-Executive Director,Chairman |
2016-11-21 | Mr. Michael Charles Buzzacott | Non-Executive Director |
2024-09-12 | Ms. Lesley Mary Samuel Knox OBE | Non-Executive Director,Senior Independent Director; Workforce Engagement Director |
2014-10-08 | Mr. John Graham Worby | Executive Director,Finance Director |
2024-09-06 | Mr. Iain George Thomas Ferguson CBE | Non-Executive Director,Chairman |
2011-08-09 | Mr. David Peter Timmins | Executive Director,Finance Director |
2009-05-18 | Mr. John Eric Hawkins | Non-Executive Director,Chairman |
2013-10-10 | Mr. Ian Brian Farrelly | Company Secretary |
2019-10-15 | Mr. Daniel William David Hartley | Group General Counsel & Company Secretary |
2007-11-01 | Ms. Edwin William White | Non-Executive Director |
2011-08-09 | Mr. Martin Brett Boden | Executive Director,Group Finance Director |
2020-10-16 | Mr. Karim Bitar | Executive Director,Chief Executive Officer |
2024-09-16 | Mr. Jorgen Kokke | Executive Director,Chief Executive Officer |
2023-11-22 | Mr. Lykele van der Broek | Non-Executive Director,Work Force Engagement Director |
2024-10-14 | Ms. Alison Jane Henriksen | Executive Director,Chief Financial Officer |
Genus PLC Contact Details
Company Name | Genus PLC |
---|---|
Address | Matrix House, Basing View, Basingstoke, RG21 4DZ |
Telephone | +44 1256347100 |
Website | https://www.genusplc.com |
Genus PLC Advisors
Solicitor | Herbert Smith Freehills LLP |
---|---|
Phone | +44 2073748000 |
Fax | +44 2073740888 |
Auditor | Deloitte LLP |
---|---|
Phone | +44 1189508141 |
Fax | +44 1189508101 |
Remuneration Consultant | PricewaterhouseCoopers LLP |
---|---|
Phone | +44 205835000 |
Fax | +44 208224652 |
Financial Adviser | HSBC Bank PLC |
---|---|
Phone | (020) 7991 8888 |
Fax | (020) 7991 4459 |
Financial Adviser | HSBC Bank PLC |
---|---|
Phone | +44 2079918888 |
Fax | +44 2079914459 |
Registrar | Equiniti Limited |
---|
Stockbroker | Peel Hunt LLP |
---|---|
Phone | +44 2074188900 |
Fax | +44 2074188848 |
Financial PR Adviser | Buchanan |
---|---|
Phone | +44 2074665000 |
Fax | +44 2074665001 |
Stockbroker | Liberum Capital Limited |
---|---|
Phone | +44 2031002000 |
Fax | +44 2031002299 |
Bank | Barclays Bank PLC |
---|
Most Read
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
Company | Price | % Chg |
---|---|---|
Games Workshop Group PLC | 13,730.00 | 17.25 |
Clarkson PLC | 3,935.00 | 9.31 |
Ithaca Energy PLC | 115.60 | 6.06 |
Diploma PLC | 4,466.00 | 5.78 |
Puretech Health PLC | 171.20 | 5.68 |
Itv PLC | 65.50 | 5.56 |
Fallers
Company | Price | % Chg |
---|---|---|
Cmc Markets PLC | 264.00 | -8.49 |
Close Brothers Group PLC | 200.40 | -6.53 |
W.A.G Payment Solutions PLC | 81.60 | -4.00 |
Investec PLC | 593.50 | -2.94 |
Goodwin PLC | 6,600.00 | -2.94 |
Fidelity China Special Situations PLC | 205.50 | -2.84 |